Rite Aid Intrinsic Value Calculator – 2023: Invest in Rite Aid Corporation with a Beta Value of 1.18 and 1.21 Million Shares Traded in Last Trading Session

Trending News ☀️

Rite Aid ($NYSE:RAD) Corporation is a strong investment for any portfolio.

In addition, the company has a history of stable growth, making it a low-risk investment. This diversity allows investors to benefit from the company’s presence in different markets and industries. It also provides stability, with its long-term growth rate remaining steady despite changes in the economy and external factors. This company is well-positioned to take advantage of current and future market trends. With its stable growth rate, diverse product range, and solid financial performance, Rite Aid Corporation is an excellent option for investors looking to capitalize on the current market climate.

Market Price

Rite Aid Corporation is an attractive investment opportunity for those looking to diversify their portfolio in the retail pharmacy and health care sector. The company saw 1.21 million shares exchanged in its last trading session, and on Thursday, the stock opened at $3.5, and closed at $3.3, falling 4.9% from the previous closing price of $3.5. For those looking to capitalize on Rite Aid Corporation’s potential in 2023, this could be the ideal time to invest in the company and reap the rewards in the long run. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Rite Aid. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Rite Aid. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Rite Aid. More…

Key Ratios Snapshot

Some of the financial key ratios for Rite Aid are shown below. More…

Analysis – Rite Aid Intrinsic Value Calculator

At GoodWhale, we have conducted a comprehensive analysis of RITE AID‘s fundamentals and have concluded that the fair value of its stock should be around $11.8. Our proprietary Valuation Line was used to arrive at this figure. Currently, RITE AID’s stock is trading at a price of $3.3, which is significantly lower than our estimated fair value. This discrepancy indicates that the stock is undervalued by 72.0%. This could present an attractive opportunity for investors to buy into the company at a lower price than what would be expected based on its fundamentals. More…

Peers

The company operates through a network of approximately 4,600 stores in 31 states. Rite Aid Corp is the third largest pharmacy chain in the US. The company’s main competitors are COSMOS Pharmaceutical Corp, Clicks Group Ltd, Yifeng Pharmacy Chain Co Ltd.

– COSMOS Pharmaceutical Corp ($TSE:3349)

COSMOS Pharmaceutical Corp is a Japanese pharmaceutical company with a market cap of 575.37B as of 2022. The company’s return on equity is 10.84%. The company develops and manufactures prescription drugs, over-the-counter drugs, and medical devices. The company’s products include treatments for cancer, diabetes, and infectious diseases.

– Clicks Group Ltd ($OTCPK:CLCGY)

Clicks Group Ltd is a South African company that operates in the healthcare and beauty retail sector. The company operates through two segments: Retail and Supplies. The Retail segment comprises of Clicks, GNC, The Body Shop, and Musica. The Supplies segment includes UPD, the leading pharmaceutical and medical wholesaler in Southern Africa. Clicks Group Ltd has a market cap of 4.32B as of 2022. The company has a Return on Equity of 46.27%.

– Yifeng Pharmacy Chain Co Ltd ($SHSE:603939)

Yifeng Pharmacy Chain Co Ltd has a market cap of 41.14B as of 2022, a Return on Equity of 12.88%. Yifeng is a pharmacy chain in China with over 1,000 stores. The company offers prescription and over-the-counter drugs, as well as health and beauty products.

Summary

Rite Aid Corporation is a retail drugstore chain in the United States. Investing in Rite Aid Corporation can be a risky endeavor due to its Beta Value, which indicates it is more volatile than the overall stock market. It would be wise to review all available information and research company performance before investing in this stock. Analyzing past financials, profits and losses, and news can help investors make informed decisions on whether they should invest in this company.

Additionally, investors should consider the amount of trading volume to get an accurate assessment of the stock’s performance. Lastly, it is important to follow the company’s progress and watch for news or other developments that could affect its stock price.